Position in GLUE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,612,817
+$5,763,017 QoQ
Shares Held
934,414
-8.8% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 193 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. GLUE ranks #139 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in GLUE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,612,817 | 934,414 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,849,800 | 1,024,304 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,385,504 | 1,300,096 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $20,838,779 | 2,812,251 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,319,032 | 2,288,034 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,687,860 | 4,674,108 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $38,506,228 | 5,548,448 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,037,488 | 5,101,413 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $19,055,201 | 5,094,974 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $37,652,653 | 5,340,802 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $31,285,399 | 5,537,239 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $28,763,149 | 6,004,833 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $44,838,263 | 6,545,732 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $50,019,893 | 6,421,039 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $47,314,854 | 6,217,458 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $50,694,635 | 6,204,974 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $60,075,299 | 6,212,544 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $98,063,562 | 6,994,548 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $142,447,612 | 6,975,887 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $155,008,286 | 6,957,284 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $97,888,279 | 4,312,259 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||